Adverse effects such as tachycardia, infections, headaches, dizziness, nausea, vomiting, diarrhea, and dyspepsia, as well as contraindications such as a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, hypersensitivity, severe gastrointestinal diseases, renal impairment, and pregnancy have been noted
Molecules , 27:233
Most patients find that nausea peaks around days 3-5 after a dose increase and subsides by day 10-14 as adaptation occurs
Expected timeline: Weeks 1-3: Body adaptation, selank anxiolytic effects may be noticeable Weeks 4-6: Reduction in inflammatory markers, possible decrease in minor flare frequency Weeks 7-12: Cumulative benefits in energy, joint comfort, and immune stability This protocol adds KPV for targeted anti-inflammatory action and selank for immune modulation plus stress management